What's in iRenix Medical, Inc.'s pipeline?

iRenix Medical, Inc. has 2 drugs in our index: 1 marketed, 0 filed, 1 in Phase 3, 0 in Phase 2, 0 in Phase 1.

Which companies overlap with iRenix Medical, Inc.'s portfolio?

Top competitors by shared drug class: ADMA Biologics, Inc., Baxalta now part of Shire, Bio Products Laboratory, Biotest, CSL Behring.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/irenix-medical-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-17 · How we verify

iRenix Medical, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

iRenix Medical, Inc. pipeline: 1 marketed, 0 filed, 1 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

1 marketed 0 filed 1 Phase 3 0 Phase 2 0 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area	First approval
Providone-Iodine	Providone-Iodine	marketed	Antiseptic/Disinfectant		Dermatology/Infection Prevention
IRX-101	IRX-101	phase 3	Intravenous immunoglobulin (IVIG)	Fc receptors, complement system	Immunology

Therapeutic area mix

Dermatology/Infection Prevention · 1
Immunology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ADMA Biologics, Inc. · 1 shared drug class
Baxalta now part of Shire · 1 shared drug class
Bio Products Laboratory · 1 shared drug class
Biotest · 1 shared drug class
CSL Behring · 1 shared drug class
CSL Limited · 1 shared drug class
Case Western Reserve University · 1 shared drug class
Centre Hospitalier Universitaire de Saint Etienne · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for iRenix Medical, Inc.:

Cite this brief

Drug Landscape (2026). iRenix Medical, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/irenix-medical-inc. Accessed 2026-05-17.